Fig. 4: NLCs EVs induce gene expression changes in CLL-B-cells.

A Principal component analysis (PCA) of RNAseq data transcripts of patients’ CLL-B-cells treated (“NLCs EVs”) or not (“Untreated”) with NLCs EVs. (Patients #10, 12 & 13- Supplementary Table 1). B Volcano plot showing differential expression of genes (DEG) with FDR < 0.05 in CLL-B-cells from patients treated with NLCs EVs. C Heatmap displaying the results of a hierarchical clustering of all differentially expressed genes between CLL-B-cells treated with NLCs EVs versus those untreated. D Differential expression of selected genes following NLCs EVs treatment of CLL-B-cells.